The results showed that MITF expression was significantly associated with OS and progression-free survival (PFS) in lung adenocarcinoma (p-value 0.047 was for OS and 0.034 for PFS, log-rank test) (Supplementary Figure 1B, 1C). This evidence concerns the gene MITF and lung adenocarcinoma.